Adults who inhaled steroids as children to control their asthma may be shorter than they otherwise would have been, but only by a little, U.S. researchers said on Monday.
A National Tsing Hua University research team has made a breakthrough in bio-imaging technology that will enable researchers to study stem cells more closely and cheaply.
The U.S. Food and Drug Administration (FDA) warned physicians and caregivers on Wednesday about the risks of giving the pain reliever codeine to children who have just had surgery to treat obstructive sleep apnea.
The top 10 imported Chinese medicines are to require safety certification beginning Aug. 1, as well as improved labeling, a Department of Health (DOH) official said yesterday.
U.S. regulators on Tuesday approved the second new anti-obesity drug in 13 years, Qsymia, for use with exercise and a good diet in people who are obese or overweight with certain medical problems.
The first-ever daily pill to help prevent against HIV was approved Monday by U.S. regulators for use in uninfected adults who are at risk for getting the virus that causes AIDS.
ScinoPharm Taiwan Ltd., one of the leading biotechnology companies in the country, said Friday it plans to invest NT$1.1 billion (US$37.6 million) in a project to manufacture high-potency injectable drugs for cancer treatment.
Taiwan's emergency rooms (ER) face a serious imbalance between the number of doctors and patients, with the former keen to leave their jobs while the latter tend to abuse medical services, a research noted yesterday.
The Department of Health proposed a set of solutions to the increasing shortage of emergency room (ER) doctors Saturday, amid accusations that they are underpaid and overworked. The solutions include a cash reward of NT$120,000 (US$4,008) per year for physicians who have completed ER training, enhancement of safe work environments and plans to encourage transfer of patients from ER to other units, according to a statement released by the department.